These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32289501)

  • 81. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
    Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
    Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection.
    Carlsson B; Kindberg E; Buesa J; Rydell GE; Lidón MF; Montava R; Abu Mallouh R; Grahn A; Rodríguez-Díaz J; Bellido J; Arnedo A; Larson G; Svensson L
    PLoS One; 2009; 4(5):e5593. PubMed ID: 19440360
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Norovirus genotype diversity associated with gastroenteritis outbreaks in Victoria in 2013.
    Bruggink LD; Dunbar NL; Catton MG; Marshall JA
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E34-41. PubMed ID: 26063096
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Population-Level Human Secretor Status Is Associated With Genogroup 2 Type 4 Norovirus Predominance.
    Arrouzet CJ; Ellis K; Kambhampati A; Chen Y; Steele M; Lopman B
    J Infect Dis; 2020 May; 221(11):1855-1863. PubMed ID: 31900482
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination.
    Lindesmith LC; McDaniel JR; Changela A; Verardi R; Kerr SA; Costantini V; Brewer-Jensen PD; Mallory ML; Voss WN; Boutz DR; Blazeck JJ; Ippolito GC; Vinje J; Kwong PD; Georgiou G; Baric RS
    Immunity; 2019 Jun; 50(6):1530-1541.e8. PubMed ID: 31216462
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A split NanoLuc complementation-based human norovirus-like particle entry assay facilitates evaluation of anti-norovirus antibodies in live cells.
    Qiao W; Wang S; Zhang C; Huang Z
    Antiviral Res; 2022 Jan; 197():105231. PubMed ID: 34965447
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Human noroviruses: recent advances in a 50-year history.
    Atmar RL; Ramani S; Estes MK
    Curr Opin Infect Dis; 2018 Oct; 31(5):422-432. PubMed ID: 30102614
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Norovirus Infection and Histo-blood Group Antigens in Children Hospitalized with Diarrhea in Lulong and Chenzhou in China.
    Sun XM; Yan XF; He ZG; Li JX; Guo NJ; Xu ZQ; Jin M; Li DD; Zhou YK; Xie GC; Pang LL; Zhang Q; Liu N; Duan ZJ
    Biomed Environ Sci; 2016 Apr; 29(4):286-9. PubMed ID: 27241739
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.
    Lindesmith LC; Mallory ML; Jones TA; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    J Infect Dis; 2017 Mar; 215(6):984-991. PubMed ID: 28453838
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Detection of Norovirus in Saliva Samples from Acute Gastroenteritis Cases and Asymptomatic Subjects: Association with Age and Higher Shedding in Stool.
    Anfruns-Estrada E; Sabrià A; Fuentes C; Sabaté S; Razquin E; Cornejo T; Bartolomé R; Torner N; Izquierdo C; Soldevila N; Coronas L; Dominguez A; Pintó RM; Bosch A; Guix S; The Working Group For The Study Of Outbreaks Of Acute Gastroenteritis In Catalonia Pi/
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33266188
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.
    Hansman GS; Biertümpfel C; Georgiev I; McLellan JS; Chen L; Zhou T; Katayama K; Kwong PD
    J Virol; 2011 Jul; 85(13):6687-701. PubMed ID: 21525337
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30678195
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The effect of proteolytic enzymes and pH on GII.4 norovirus, during both interactions and non-interaction with Histo-Blood Group Antigens.
    Chassaing M; Robin M; Loutreul J; Majou D; Belliot G; de Rougemont A; Boudaud N; Gantzer C
    Sci Rep; 2020 Oct; 10(1):17926. PubMed ID: 33087754
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viral Immunol; 2016 Jun; 29(5):315-9. PubMed ID: 27135874
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Secretors of HBGA and Susceptibility to Norovirus and Rotavirus Diarrhea.
    Faden H; Schaefer BA
    Pediatr Infect Dis J; 2021 Sep; 40(9):846-851. PubMed ID: 34397778
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Analyses of Binding Profiles of the GII. 12 Norovirus with Human Histo-blood Group Antigens].
    Jin M; Chen K; Song J; Li H; Zhang Q; Kong X; Liu N; Duan Z
    Bing Du Xue Bao; 2015 Mar; 31(2):164-9. PubMed ID: 26164942
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human norovirus infection and the acute serum cytokine response.
    Newman KL; Moe CL; Kirby AE; Flanders WD; Parkos CA; Leon JS
    Clin Exp Immunol; 2015 Nov; 182(2):195-203. PubMed ID: 26178578
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Characterisation of a household norovirus outbreak occurred in Valencia (Spain).
    Carmona-Vicente N; Fernández-Jiménez M; Vila-Vicent S; Rodríguez-Díaz J; Buesa J
    BMC Infect Dis; 2016 Mar; 16():124. PubMed ID: 26968797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.